Figure A (Figureav2)
Rufinamide Suspension
Product Images NDC 69452-223
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 69452-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Figureb)
Figure C (Figurec)
A device which can be attached to a bottle to facilitate various tasks like dispensing liquid or creating a makeshift watering can.*
Figure D (Figured)
Figure E (Figureev2)
Figure F (Figurefv2)
Figure G (Figuregv2)
Figure H (Figurehv2)
Figure I (Figureiv2)
Figure J (Figurejv2)
Figure K (Figurek)
Image001
This is a description of a Rufinamide oral suspension medication with a concentration of 40mg/mL. The product comes with two 20mL oral syringes for administration, and the recommended dosage should be based on the full prescribing information provided. The medication should be shaken well before use, and each enclosed full prescribing information should contain instructions for administration. The product code is NDC 69452-223-84, and it is distributed by Blonghama e at 600 AandorFoad, Pincson, 108540. The expiry date for the medication is 100 days from opening, and it should be stored at 25°C (77°F) with excursions permitted up to 16°-30°C (60°-86°F) as per USP Controlled room temperature guidelines. The medication is available only on a prescription from the pharmacist.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
